Live Breaking News & Updates on Patient Care Research Database

Stay updated with breaking news from Patient care research database. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Evaluation of the oral corticosteroid-sparing effect of tezepelumab in adults with oral corticosteroid-dependent asthma (SOURCE): a randomised, placebo-controlled, phase 3 study

Evaluation of the oral corticosteroid-sparing effect of tezepelumab in adults with oral corticosteroid-dependent asthma (SOURCE): a randomised, placebo-controlled, phase 3 study
thelancet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thelancet.com Daily Mail and Mail on Sunday newspapers.

United States , United Kingdom , South Korea , Patient Care Research Database , European Respiratory Society , American Thoracic Society , Global Initiative For Asthma , Optimum Patient Care Research Database , British Thoracic Difficult Asthma , Asthma Allergy , Englj Med , Allergy Clin Immunol , Rheum Dis ,

Update On SOURCE Phase 3 Trial For Tezepelumab In Patients With Severe, Oral Corticosteroid-Dependent Asthma


Update On SOURCE Phase 3 Trial For Tezepelumab In Patients With Severe, Oral Corticosteroid-Dependent Asthma
Amgen and AstraZeneca today announced the SOURCE trial did not meet the primary endpoint of a statistically significant reduction in the daily oral corticosteroid dose, without loss of asthma control, with tezepelumab compared to placebo. The 48-week trial assessed the efficacy and safety of the potential new medicine tezepelumab compared to placebo in 150 severe asthma patients who required maintenance use of oral …
Amgen (NASDAQ:AMGN) and AstraZeneca today announced the SOURCE trial did not meet the primary endpoint of a statistically significant reduction in the daily oral corticosteroid (OCS) dose, without loss of asthma control, with tezepelumab compared to placebo. ....

Puerto Rico , United States , United Kingdom , Lymphopoietin Isoforms , Megan Fox , Trish Rowland , Davidm Reese , Exchange Commission , Clinical Trial Program , Patient Care Research Database , Drug Administration , Beigene Ltd , Breakthrough Therapy Designation , Astrazeneca Collaboration , North America , Trial Program , Amgen Board , Thousand Oaks , Respir Rev , Thymic Stromal Lymphopoietin Isoforms , Inflammatory Disorders , Front Immunol , Uncontrolled Asthma , Patient Centered Description , Severe Asthma , Patient Understanding Leading ,